Acurx Pharmaceuticals's total assets for Q3 2024 were $6.02M, a decrease of -8.51% from the previous quarter. ACXP total liabilities were $3.32M for the fiscal quarter, a 5.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.